Label: DR. RECKEWEG R74 NOCTURNIN COMBINATION PRODUCT- ferrum phosphoricum 8x, kali phosphoricum 12x, pulsatilla 12x, sepia 6x, calcarea phosphorica 30x, causticum 30x liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved homeopathic

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Label Information

Updated April 3, 2013

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active ingredients

    Ferrum phosphoricum 8X 2 g, Kali phosphoricum 12X 2 g, Pulsatilla 12X 2 g, Sepia 6X 2 g, Calcarea phosphorica 30X 1 g, Causticum 30X 1 g in 10 g.

  • PURPOSE


    Purpose

    Relieves symptoms associated with enuresis


  • INDICATIONS & USAGE


    Uses

    For the temporary relief of symptoms associated with enuresis:


    • Common incontinence (involuntary urination)

  • WARNINGS


    Warnings

    Stop use and ask a doctor if symptoms persist, get worse, or if new symptoms occur.

    If pregnant or breastfeeding, ask a health care professional before use.

    Keep out of reach of children.

  • DOSAGE & ADMINISTRATION

    Directions
    Adults and children ≥ 12 years 5-10 drops 1-3 times daily in a little water or undiluted or as recommended.

  • OTHER SAFETY INFORMATION

    Other information

    • Tamper resistant: Do not use if safety ring at base of cap is broken.
    • Retain outer carton for full product information.
  • INACTIVE INGREDIENT

    Inactive ingredients

    Ethanol, purified water.

  • QUESTIONS


    Questions?

    Call 1-800-361-7872 or email questions@reckeweg.com
  • PRINCIPAL DISPLAY PANEL

    image of carton label

    NDC# 53346-1374-5

    Dr. Reckeweg R74 Nocturnin

    Homeopathic preparation for the temporary relief of symptoms associated with enuresis:

    •  Common incontinence (involuntary urination)


    Manufactured by:

    Dr. Reckeweg Co. GmbH

    D-64625 Bensheim

    Germany

    1.68 fl oz
    (50 ml)

  • INGREDIENTS AND APPEARANCE
    DR. RECKEWEG R74 NOCTURNIN  COMBINATION PRODUCT
    ferrum phosphoricum 8x, kali phosphoricum 12x, pulsatilla 12x, sepia 6x, calcarea phosphorica 30x, causticum 30x liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53346-1374
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FERRIC PHOSPHATE (UNII: N6BAA189V1) (FERRIC CATION - UNII:91O4LML611) FERRIC CATION8 [hp_X]  in 50 mL
    POTASSIUM PHOSPHATE, DIBASIC (UNII: CI71S98N1Z) (PHOSPHATE ION - UNII:NK08V8K8HR) POTASSIUM PHOSPHATE, DIBASIC12 [hp_X]  in 50 mL
    PULSATILLA PRATENSIS (UNII: 8E272251DI) (PULSATILLA PRATENSIS - UNII:8E272251DI) PULSATILLA PRATENSIS12 [hp_X]  in 50 mL
    SEPIA OFFICINALIS JUICE (UNII: QDL83WN8C2) (SEPIA OFFICINALIS JUICE - UNII:QDL83WN8C2) SEPIA OFFICINALIS JUICE6 [hp_X]  in 50 mL
    CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP) (CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS - UNII:L11K75P92J) CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE30 [hp_X]  in 50 mL
    CAUSTICUM (UNII: DD5FO1WKFU) (CAUSTICUM - UNII:DD5FO1WKFU) CAUSTICUM30 [hp_X]  in 50 mL
    Inactive Ingredients
    Ingredient NameStrength
    ALCOHOL (UNII: 3K9958V90M)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:53346-1374-550 mL in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic06/01/1986
    Labeler - PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO (318602612)
    Establishment
    NameAddressID/FEIBusiness Operations
    PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO318602612manufacture(53346-1374)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!